Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risdiplam, the First Approved Small Molecule Splicing Modifier Drug as a Blueprint for Future Transformative Medicines
Hasane Ratni, R. Scalco, Alexander Stephan
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 874-877
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
Christopher M. Marshall, John G. Federice, Chloe N. Bell, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11622-11655
Closed Access | Times Cited: 70
Advances and limitations for the treatment of spinal muscular atrophy
John Day, Kelly Howell, Amy Place, et al.
BMC Pediatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 65
The era of cryptic exons: implications for ALS-FTD
Puja R. Mehta, Anna‐Leigh Brown, Michael E. Ward, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 52
Small molecule approaches to targeting RNA
Sandra Kovachka, Marc Panosetti, Benedetto Grimaldi, et al.
Nature Reviews Chemistry (2024) Vol. 8, Iss. 2, pp. 120-135
Open Access | Times Cited: 28
Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery
Amanda L. Garner
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 3, pp. 251-259
Open Access | Times Cited: 24
Specificity, synergy, and mechanisms of splice-modifying drugs
Yuma Ishigami, Mandy S. Wong, Carlos Martí‐Gómez, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
The Plethora of RNA–Protein Interactions Model a Basis for RNA Therapies
Stephen Dansereau, Hua Cui, Ricky Dartawan, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 48-48
Open Access
Pyridazine: A privileged scaffold in the development of 21st-century pesticides
Chao Chen, Geng Wang, Ke Li, et al.
Chinese Chemical Letters (2025), pp. 110902-110902
Closed Access
CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew S. Macauley
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101111-101111
Closed Access | Times Cited: 33
Synthetic Approaches to the New Drugs Approved During 2020
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9607-9661
Closed Access | Times Cited: 26
Pre-mRNA splicing-associated diseases and therapies
Sierra L. Love, Joseph D. Emerson, Kazunori Koide, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 525-538
Open Access | Times Cited: 18
Synthetic Routes to Approved Drugs Containing a Spirocycle
Nazar Moshnenko, Alexander Kazantsev, Evgeny Chupakhin, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4209-4209
Open Access | Times Cited: 17
Base editing as a genetic treatment for spinal muscular atrophy
Christiano R. R. Alves, Leillani L. Ha, Rebecca Yaworski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 15
Drugging RNA
Ken Garber
Nature Biotechnology (2023) Vol. 41, Iss. 6, pp. 745-749
Open Access | Times Cited: 14
The diversity of splicing modifiers acting on A-1 bulged 5′-splice sites reveals rules for rational drug design
Florian Malard, Antje C Wolter, Julien Marquevielle, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 8, pp. 4124-4136
Open Access | Times Cited: 5
Live Cell Screening to Identify RNA-Binding Small Molecule Inhibitors of the pre-let-7-Lin28 RNA-Protein Interaction
Sydney L. Rosenblum, Dalia M. Soueid, George M. Giambaşu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1539-1546
Open Access | Times Cited: 3
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy
Christiano R. R. Alves, Leillani L. Ha, Rebecca Yaworski, et al.
Nature Biomedical Engineering (2023)
Open Access | Times Cited: 10
Protein-Based Virtual Screening Tools Applied for RNA–Ligand Docking Identify New Binders of the preQ1-Riboswitch
Elisabeth Kallert, Tim R. Fischer, Simon Schneider, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 17, pp. 4134-4148
Open Access | Times Cited: 15
Risdiplam for the treatment of adults with spinal muscular atrophy: Experience of the Northern Ireland neuromuscular service
Gavin McCluskey, Siobhan Lamb, Sarah Mason, et al.
Muscle & Nerve (2022) Vol. 67, Iss. 2, pp. 157-161
Open Access | Times Cited: 15
Targeting RNA‐binding proteins with small molecules: Perspectives, pitfalls and bifunctional molecules
Qingxin Li, CongBao Kang
FEBS Letters (2023) Vol. 597, Iss. 16, pp. 2031-2047
Open Access | Times Cited: 8
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence
Salvatore Crisafulli, Brigida Boccanegra, Giacomo Vitturi, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1446-1446
Open Access | Times Cited: 8
Male Reproduction in Spinal Muscular Atrophy (SMA) and the Potential Impact of Oral Survival of Motor Neuron 2 (SMN2) Pre-mRNA Splicing Modifiers
Natan Bar‐Chama, Bakri Elsheikh, Channa Hewamadduma, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 933-947
Open Access | Times Cited: 2
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
(2024)
Open Access | Times Cited: 2
Large-Scale Crystallographic Fragment Screening Expedites Compound Optimization and Identifies Putative Protein–Protein Interaction Sites
T. Barthel, J. Wollenhaupt, G.M.A. Lima, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14630-14641
Closed Access | Times Cited: 11
Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China
Xiaoli Yao, Jing Peng, Rong Luo, et al.
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 5378-5391
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top